Rui Pinto Selected Research

Carcinogenesis

1/2011	Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model.
1/2010	Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.
9/2009	Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rui Pinto Research Topics

Disease

17	Inflammation (Inflammations) 01/2024 - 08/2007
12	Colitis 09/2023 - 01/2017
7	Interstitial Cystitis (Interstitial Cystitis, Chronic) 11/2022 - 09/2010
6	Neoplasms (Cancer) 05/2022 - 09/2009
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2022 - 01/2017
4	Pain (Aches) 01/2023 - 05/2014
4	Body Weight (Weight, Body) 05/2022 - 08/2007
4	Wounds and Injuries (Trauma) 07/2021 - 11/2006
3	Chronic Renal Insufficiency 12/2022 - 01/2010
3	Lower Urinary Tract Symptoms 01/2017 - 06/2011
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2016 - 02/2009
3	Ischemia 04/2015 - 11/2002
3	Carcinogenesis 01/2011 - 09/2009
2	Arteriovenous Fistula 08/2023 - 09/2022
2	Necrosis 12/2022 - 07/2021
2	Hyperemia 05/2022 - 10/2019
2	Ulcer 05/2022 - 10/2019
2	Infections 07/2021 - 06/2018
2	Animal Disease Models 07/2021 - 10/2019
2	Fabry Disease (Fabry's Disease) 01/2018 - 01/2017
2	Chronic Disease (Chronic Diseases) 01/2018 - 07/2009
2	Stress Urinary Incontinence 01/2017 - 07/2009
2	Obesity 04/2013 - 01/2013
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2010 - 09/2009
2	Urinary Retention 08/2009 - 01/2008
2	Reperfusion Injury 11/2006 - 11/2002
1	Periodontitis 01/2024
1	Ebola Hemorrhagic Fever 01/2024
1	COVID-19 04/2023
1	Coinfection 04/2023
1	Sepsis (Septicemia) 04/2023
1	Pelvic Pain 01/2023
1	Cholecystitis 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2022
1	Coronary Disease (Coronary Heart Disease) 12/2022
1	Cholelithiasis 12/2022
1	Osteoporosis 07/2022
1	Colitis-Associated Neoplasms 05/2022

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 05/2022 - 11/2015
5	Erythropoietin FDA Link 12/2022 - 11/2006
4	AcidsIBA 12/2022 - 10/2019
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 09/2009
4	Type A Botulinum Toxins (Botox)FDA Link 06/2011 - 01/2008
3	InterleukinsIBA 05/2022 - 01/2018
3	Sulfonic AcidsIBA 04/2022 - 01/2018
3	Insulin (Novolin)FDA Link 11/2021 - 08/2007
3	CarrageenanIBA 06/2019 - 07/2009
3	Nerve Growth Factor (NGF)IBA 01/2017 - 01/2013
3	onabotulinum toxin AIBA 12/2016 - 02/2013
2	Docosahexaenoic AcidsIBA 12/2022 - 11/2015
2	CalciumIBA 07/2022 - 01/2019
2	Trinitrobenzenesulfonic AcidIBA 05/2022 - 10/2019
2	Hemin (Panhematin)FDA Link 01/2022 - 01/2018
2	CytokinesIBA 07/2021 - 01/2018
2	Therapeutic UsesIBA 07/2020 - 02/2013
2	LipopolysaccharidesIBA 07/2020 - 06/2015
2	AntioxidantsIBA 01/2020 - 09/2009
2	Peroxidase (Myeloperoxidase)IBA 10/2019 - 01/2018
2	Interleukin-10 (Interleukin 10)IBA 10/2019 - 01/2018
2	4- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA 01/2018 - 04/2015
2	sym-trinitrobenzeneIBA 01/2018 - 01/2018
2	Nerve Growth Factors (Neurotrophins)IBA 01/2017 - 01/2013
2	CatecholaminesIBA 06/2015 - 01/2010
2	Adrenergic Agents (Adrenergic Drugs)IBA 06/2015 - 07/2009
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2015 - 11/2002
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2014 - 01/2013
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2014 - 01/2013
2	LipidsIBA 02/2014 - 04/2013
2	C-Reactive ProteinIBA 04/2013 - 08/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013 - 01/2010
2	Uric Acid (Urate)IBA 04/2013 - 01/2013
2	incobotulinumtoxinA FDA Link 06/2011 - 08/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2010 - 09/2009
2	Celecoxib (Celebrex)FDA Link 01/2010 - 09/2009
1	Silk FDA Link 01/2024
1	carbamylated erythropoietinIBA 09/2023
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 12/2022
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 12/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 11/2022
1	silodosin FDA Link 09/2022
1	Topiramate (Topamax)FDA LinkGeneric 08/2022
1	Vitamin D FDA LinkGeneric 07/2022
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 07/2022
1	AzoxymethaneIBA 05/2022
1	Dextran SulfateIBA 05/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2022
1	Dimenhydrinate (DMH)FDA LinkGeneric 05/2022

Therapy/Procedure

7	Therapeutics 01/2024 - 11/2002
2	Renal Dialysis (Hemodialysis) 08/2023 - 09/2022
2	Rectal Administration 04/2022 - 10/2019
2	Suburethral Slings (Tension-Free Vaginal Tape) 01/2017 - 07/2009
2	Osteotomy 10/2016 - 04/2011
1	Ligation 01/2024
1	Immunotherapy 04/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2023
1	Intraperitoneal Injections 12/2022